The department aims to provide compassionate, state-of-the-art care for cancer patients and continued advancements in the prevention, diagnosis, treatment and cure of cancer via a combination of research, education and clinical practice.
The department’s focus is firmly on the development of new agents for the treatment of cancer. We participate in phase one, two and three clinical trials using novel agents that are not available outside clinical trials, so our patients benefit from early access to the agents. For more information about the oncology clinical trials program please visit our trials web page Cancer Trials at Cabrini.
Our research also has a significant focus on patient outcomes, particularly looking at tools and interventions to improve the patient experience through better quality-of-life, less toxicity, and better patient survivorship. Please email enquiries about translational research projects and collaboration opportunities to Research Fellow Dr Tali Lang firstname.lastname@example.org
Professor Gary Richardson OAM
Li Hoon Lai